4.6 Review

A synthetic biology approach to engineering circuits in immune cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Programming multicellular assembly with synthetic cell adhesion molecules

Adam J. Stevens et al.

Summary: Cell adhesion molecules play a crucial role in various cellular processes, and their synthetic counterparts can be generated by combining extracellular interactions with intracellular domains. These synthetic molecules allow for customized cell-cell interactions with properties similar to native interactions. The intracellular domains determine the interface morphology and mechanics, while the extracellular interaction domains specify the connectivity between cells. This toolkit of synthetic cell adhesion molecules enables the assembly of multicellular architectures and the systematic remodeling of native tissues, providing insights into the evolution of different classes of cell-cell interfaces. Overall, these tools have significant implications for cell and tissue engineering and the study of multicellular organization.

NATURE (2023)

Review Oncology

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

Christian L. Flugel et al.

Summary: CAR T cells targeting solid tumour antigens carry a higher risk of on-target, off-tumour toxicity (OTOT), and this article summarizes the available data on OTOT and describes novel CAR T cell designs to overcome such toxicities.

NATURE REVIEWS CLINICAL ONCOLOGY (2023)

Article Oncology

CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses

Camilla Bove et al.

Summary: This study investigated the role of CD4 and CD8 T cells in CD19 CAR-T cell responses and the development of cytokine release syndrome (CRS). CD4 CAR-T cells exhibited superior proliferation and activation potential compared to CD8 CAR-T cells. CD4 CAR-T cells were found to play a key role in the development of CRS, and CD4 CAR-T cells with embedded 4-1BB were associated with a safer profile. CD4 cells were crucial for maintaining long-term responses and the combination of CD4.BBz with CD8.28z CAR-T cells resulted in the lowest toxicity without compromising antitumor efficacy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Review Oncology

The evolving tumor microenvironment From cancer initiation to metastatic outgrowth

Karin E. de Visser et al.

Summary: Cancers consist of tumor cells and various non-cancerous cells in an altered extracellular matrix, forming complex ecosystems. The tumor microenvironment (TME) includes different immune cell types, cancer-associated fibroblasts, endothelial cells, pericytes, and other tissue-resident cells, all of which play critical roles in cancer pathogenesis. The composition and function of the TME can vary depending on the organ, cancer cell features, tumor stage, and patient characteristics. Understanding the interplay between tumor cell-intrinsic, cell-extrinsic, and systemic factors is crucial for developing effective anti-cancer treatments.

CANCER CELL (2023)

Article Immunology

Toward a general model of CD4+T cell subset specification and memory cell formation

Kevin C. Osum et al.

Summary: In the field of CD4+ T cells, there has been a lack of progress compared to the transformative discoveries made in memory CD8+ T cell biology in recent decades. This perspective focuses on the specification of CD4+ helper T (Th) cell subsets and the formation of memory cells. The authors argue that the abundance of Th effector and memory cell subsets and the emphasis on their differences have hindered the development of a general model for CD4+ memory T cell formation applicable to all immune responses. They propose a bifurcation model based on an IL-2 signal-dependent switch to explain the balanced production of diverse Th memory cells involved in cell-mediated or humoral immunity.

IMMUNITY (2023)

Article Multidisciplinary Sciences

Co-opting signalling molecules enables logic-gated control of CAR T cells

Aidan M. Tousley et al.

Summary: Researchers have developed a new CAR T cell platform called LINK CAR, which replaces traditional CD3 zeta domains with intracellular proximal T cell signalling molecules. LINK CAR can activate T cells and eradicate tumors in vivo while bypassing certain upstream signalling proteins, showing superior efficacy and prevention of off-tumor toxicity compared to other systems. This study expands the range of molecules that can be targeted with CAR T cells, enabling their application in solid tumors, autoimmune diseases, and fibrosis, and also highlights the potential of repurposing cellular signaling machinery for cellular engineering.

NATURE (2023)

Article Multidisciplinary Sciences

CAR immune cells: design principles, resistance and the next generation

Louai Labanieh et al.

Summary: The development of next-generation CAR immune cell technologies has greatly improved the efficacy, safety, and accessibility of CAR therapies. Multispecific, logic-gated, and regulatable CARs show promise in overcoming resistance and increasing safety. Stealth, virus-free, and in vivo gene delivery platforms may reduce costs and improve access to cell therapies. The success of CAR T cells in liquid cancers is driving the development of more sophisticated immune cell therapies for solid cancers and non-malignant diseases in the future.

NATURE (2023)

Article Multidisciplinary Sciences

Engineered skin bacteria induce antitumor T cell responses against melanoma

Y. Erin Chen et al.

Summary: Certain bacterial colonists induce a specific T cell response, even in the absence of infection. By engineering a skin bacterium to express tumor antigens, researchers were able to elicit tumor-specific T cells that infiltrate lesions and possess cytotoxic activity. This reveals the potential for commensal bacteria to be harnessed therapeutically for targeted immune responses.

SCIENCE (2023)

Review Oncology

Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating

Mohamad Hamieh et al.

Summary: The success of CAR T cells in treating B-cell malignancies has opened up possibilities for treating solid tumors. However, challenges such as antigen escape and the lack of specific CAR targets need to be addressed. Recent advances in CAR T cell engineering offer potential solutions to these challenges by enhancing antigen sensitivity and enabling composite antigen recognition. These advancements have the potential to improve the clinical efficacy of CAR T cell therapies beyond B-cell malignancies.

CANCER DISCOVERY (2023)

Article Multidisciplinary Sciences

Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity

Thomas M. Savage et al.

Summary: Tumors actively exclude immune cells involved in antitumor immunity, but synthetic biology allows engineering of bacteria to recruit and activate antitumor immune responses. Bacteria expressing mutant human chemokine CXCL16 attract CD8+ T cells, while another engineered bacterial strain expressing CCL20 targets tumor-derived antigens for presentation by dendritic cells. This strategy offers a new cancer immunotherapy approach.

SCIENCE ADVANCES (2023)

Article Engineering, Biomedical

Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes

Dana V. Foss et al.

Summary: The yields of edited primary human lymphocytes can be significantly increased by delivering a CRISPR ribonucleoprotein along with an identified amphiphilic peptide. This simple delivery method allows for gene knockouts in T cells, B cells, and natural killer cells, as well as introducing a chimeric antigen receptor gene at a specific locus. The engineered cells showed antitumor potency in mice.

NATURE BIOMEDICAL ENGINEERING (2023)

Article Multidisciplinary Sciences

Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells

J. Joseph Melenhorst et al.

Summary: CAR T cells redirected to target CD19 demonstrated long-lasting potential and clonal stability in two patients with chronic lymphocytic leukaemia. Highly activated CD4(+) cells emerged and dominated the CAR T cell population at later time points. These unexpected CAR T cell populations provide novel insights into anti-cancer response and long-term remission in leukaemia.

NATURE (2022)

Article Biochemistry & Molecular Biology

The evolution of synthetic receptor systems

Janvie Manhas et al.

Summary: Researchers have repurposed natural receptors to engineer synthetic receptors that enable cells to detect and respond to their environments. By improving and integrating protein-based receptors and signal-processing components, customized functions and programming can be achieved.

NATURE CHEMICAL BIOLOGY (2022)

Article Multidisciplinary Sciences

Synthetic multistability in mammalian cells

Ronghui Zhu et al.

Summary: This study explores synthetic circuits that generate multiple stable states, providing insights into natural cell fate control circuit structures and enabling engineering of multicellular programs requiring interactions among distinct cell types.

SCIENCE (2022)

Editorial Material Medicine, General & Internal

CAR-macrophage: An extensive immune enhancer to fight cancer

Shuhang Wang et al.

EBIOMEDICINE (2022)

Review Immunology

Dendritic cells in cancer immunology

Theresa L. Murphy et al.

Summary: The clinical success of immune checkpoint therapy has led to a surge in tumor immunology research, with efforts aimed at enhancing ICT by identifying targets that synergize with existing therapies. Expanding principles through basic research may help broaden translational efforts. This review focuses on key aspects of dendritic cell biology, antigen processing, and helper cells that relate to ICT mechanisms and cell-mediated immunity.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Article Cell Biology

A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo

Mark L. Sandberg et al.

Summary: CEA Tmod cells are a potential therapeutic candidate for colorectal cancer, with the ability to selectively target tumor cells and avoid toxicity to normal tissues by exploiting HLA gene loss in tumors.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Engineering, Biomedical

Enhancing the tropism of bacteria via genetically programmed biosensors

Tiffany Chien et al.

Summary: The tropism of engineered bacteria in vivo can be enhanced by genetic circuits, linked by AND-gate logic, that couple bacterial sensing and growth. Engineered bacteria for therapeutic applications would benefit from control mechanisms that confine the growth of the bacteria within specific tissues or regions in the body. Multiplexing of genetic circuits may enhance the localization of bacteria to specified niches, providing increased specificity for therapeutic applications.

NATURE BIOMEDICAL ENGINEERING (2022)

Article Multidisciplinary Sciences

Synthetic cytokine circuits that drive T cells into immune-excluded tumors

Greg M. Allen et al.

Summary: In this study, we engineered circuits in CAR T cells to locally induce production of the cytokine IL-2 using tumor-specific synNotch receptors. These circuits enhance CAR T cell infiltration and clearance of immunosuppressive tumors, without causing systemic toxicity. The most effective IL-2 induction circuit acts in an autocrine and TCR- or CAR-independent manner, bypassing key tumor suppression mechanisms.

SCIENCE (2022)

Article Multidisciplinary Sciences

Multidimensional control of therapeutic human cell function with synthetic gene circuits

Hui-Shan Li et al.

Summary: Researchers have developed a synthetic zinc finger transcription regulator platform that allows precise control over therapeutic genes in primary T cells, expanding the capabilities of gene and cell-based therapies.

SCIENCE (2022)

Review Multidisciplinary Sciences

Engineering bacteria as interactive cancer therapies

Candice R. Gurbatri et al.

Summary: With the use of synthetic biology tools, researchers are repurposing bacteria as tumor-specific delivery systems, which can modulate the tumor microenvironment and enhance therapeutic efficacy and safety through their immunogenicity and local payload production.

SCIENCE (2022)

Article Multidisciplinary Sciences

Enhanced T cell effector activity by targeting the Mediator kinase module

Katherine A. Freitas et al.

Summary: This research identified MED12 and CCNC as key genes controlling T cell function through CRISPR knockout screening. Knockout of MED12 gene enhances antitumor activity, prolongs the effector phenotype of CAR-T and TCR-T cells, and promotes the expansion of non-engineered T cells. The study reveals the importance of Mediator in T cell effector programming and provides a new target to enhance the potency of antitumor T cell responses.

SCIENCE (2022)

Article Multidisciplinary Sciences

Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning

Kyle G. Daniels et al.

Summary: This study constructed a CAR library containing synthetic costimulatory domains and used neural networks and machine learning to decode the combinatorial grammar of CAR signaling motifs. Non-native combinations of signaling motifs were found to enhance cytotoxicity and stemness associated with tumor killing.

SCIENCE (2022)

Article Multidisciplinary Sciences

A physical wiring diagram for the human immune system

Jarrod Shilts et al.

Summary: In this study, we systematically mapped the direct protein interactions across a recombinant library that includes most of the surface proteins on human leukocytes, providing a high-confidence and quantitative view of the receptor wiring that connects human immune cells. By integrating our interactome with expression data, we identified trends in the dynamics of immune interactions and constructed a mathematical model that predicts cellular connectivity. We also developed an interactive multi-tissue single-cell atlas to infer immune interactions throughout the body and linked our receptor interactions to functional roles through protein stimulation and microscopy.

NATURE (2022)

Article Immunology

Mechanisms of CD40-dependent cDC1 licensing beyond costimulation

Renee Wu et al.

Summary: CD40 signaling in cDC1s plays a crucial role in anti-tumor immunity. It not only induces costimulatory ligands for CD8(+) T cells, but also induces Bcl2l1 that sustains cDC1 survival during the priming of the anti-tumor responses.

NATURE IMMUNOLOGY (2022)

Review Oncology

Rethinking cancer targeting strategies in the era of smart cell therapeutics

Greg M. Allen et al.

Summary: In the past, cancer therapeutics focused on precision targeting of single cancer-associated molecules, which still had limitations. However, the recent development of cell-based therapies, equipped with synthetic circuits, presents a revolutionary opportunity to target cancers in a more precise and effective way. Moreover, combining these smart cell engineering capabilities with machine learning analysis of genomic data could enhance tumor recognition and prevent tumor escape.

NATURE REVIEWS CANCER (2022)

Article Multidisciplinary Sciences

RASA2 ablation in T cells boosts antigen sensitivity and long-term function

Julia Carnevale et al.

Summary: This study identifies RASA2 as a potential target gene that can enhance the efficacy of T cell therapies for cancer treatment. Ablation of RASA2 increases the activation and cytolytic activity of T cells, leading to improved cancer cell killing. Furthermore, RASA2-deficient CAR T cells have a competitive advantage in the bone marrow and extended the survival of mice in preclinical models. These findings highlight the importance of targeting RASA2 in enhancing T cell therapies for cancer treatment.

NATURE (2022)

Article Cell Biology

Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide

Max Jan et al.

Summary: Cell-based therapies, particularly CAR T cells, are increasingly recognized as powerful agents against cancer. By utilizing the drug lenalidomide, researchers have successfully developed ON and OFF switches to control the function of CAR T cells, showing promising clinical applications for these engineered cells.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Oncology

Chimeric Antigen Receptor beyond CAR-T Cells

Vicky Mengfei Qin et al.

Summary: Chimeric antigen receptors (CAR) are engineered molecules that can recognize specific antigens and induce downstream signaling, primarily used in CAR-T cells to target and kill tumor cells. While CAR-T cell therapy has shown success in treating hematologic malignancies, current research is focusing on extending CAR technology to other immune cells for potential applications in solid tumors and autoimmune diseases. CAR technology is a powerful platform in immunotherapy with diverse applications beyond conventional CAR-T cells.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Transcriptional regulatory network for the establishment of CD8+ T cell exhaustion

Wooseok Seo et al.

Summary: Exhausted CD8(+) T cells may be deliberately generated and maintained to provide mild immune responses against chronic infection or cancer, which can be safer over the long term compared to strong immune responses. A specific population of exhausted CD8(+) T cells that behaves like self-renewing stem cells has been identified, suggesting they can be considered progenitors of exhausted CD8(+) T cells. Studies have revealed the regulatory network governing the generation and propagation of exhausted CD8(+) T cells, shedding light on the developmental stages that lead to this subtle but effective immune response.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Review Biotechnology & Applied Microbiology

Engineering living therapeutics with synthetic biology

Andres Cubillos-Ruiz et al.

Summary: Cell-based therapeutics designed with synthetic biology is an emerging strategy in medicine, utilizing genetically engineered cells for precise therapeutic control and potential treatment of various diseases. Compared to traditional therapies, synthetic biology approaches offer greater flexibility, specificity, and predictability in combating human diseases.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Multidisciplinary Sciences

T cell circuits that sense antigen density with an ultrasensitive threshold

Rogelio A. Hernandez-Lopez et al.

Summary: The study engineered a two-step positive-feedback circuit that enables human cytotoxic T cells to discriminate targets based on a sigmoidal antigen-density threshold. This circuit involves a low-affinity synthetic Notch receptor controlling the expression of a high-affinity CAR, leading to sharp discrimination between cancer cells and normal cells based on antigen density.

SCIENCE (2021)

Article Multidisciplinary Sciences

Engineering advanced logic and distributed computing in human CAR immune cells

Jang Hwan Cho et al.

Summary: The study leverages the SUPRA CAR system to develop an inhibitory feature with three-input logic, demonstrating the effectiveness of the programmable system in various immune cells. By creating a multi-cellular NIMPLY circuit, kill switch, and synthetic intercellular communication channel, the research shows that a simple split CAR design can generate diverse and complex phenotypes.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling

Evan W. Weber et al.

Summary: This study showed that transient cessation of chimeric antigen receptor (CAR) signaling can enhance the efficacy of CAR-T cells, reactivating their anti-tumor functions, and challenging the notion that exhaustion is an epigenetically fixed state.

SCIENCE (2021)

Article Cell Biology

SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models

Axel Hyrenius-Wittsten et al.

Summary: The synthetic Notch (synNotch) CAR circuits improve the specificity and persistent antitumor activity of therapeutic T cells in solid tumors by preventing CAR-mediated tonic signaling, allowing T cells to maintain long-lived memory and non-exhausted phenotype. ALPPL2 is established as a clinically viable cell therapy target for multiple solid tumors, and synNotch CAR T cells demonstrate multifaceted therapeutic benefits.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma

Joseph H. Choe et al.

Summary: By utilizing circuits that integrate recognition of multiple imperfect but complementary antigens, we have enhanced the specificity, completeness, and persistence of CAR T cells directed against glioblastoma, offering a general recognition strategy applicable to other solid tumors.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Chemistry, Multidisciplinary

Nanocomplex-Mediated In Vivo Programming to Chimeric Antigen Receptor-M1 Macrophages for Cancer Therapy

Mikyung Kang et al.

Summary: The study proposes a simple method to transform macrophages that can naturally infiltrate solid tumors into CAR-M1 macrophages with enhanced cancer-directed phagocytosis and anti-tumor activity. Injected nanocomplexes of macrophage-targeting nanocarriers and CAR-interferon-gamma-encoding plasmid DNA induce CAR-M1 macrophages capable of CAR-mediated cancer phagocytosis, tumor immunomodulation, and inhibiting solid tumor growth, providing an effective off-the-shelf CAR-macrophage therapy for solid tumors without the need for complex and costly ex vivo CAR-cell manufacturing processes.

ADVANCED MATERIALS (2021)

Article Biochemistry & Molecular Biology

A local regulatory T cell feedback circuit maintains immune homeostasis by pruning self-activated T cells

Harikesh S. Wong et al.

Summary: The study reveals that self-activated T cells in lymph nodes produce IL-2, enhancing local Treg proliferation and inhibitory function, forming a negative feedback loop. These micro-domain constraints result in transient clonal expansion followed by rapid death of self-activated T cells, maintaining immune homeostasis.
Article Immunology

BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells

Hyungseok Seo et al.

Summary: BATF and IRF4 cooperate to counter T cell exhaustion in mouse tumor models, promoting better tumor control by CAR T cells.

NATURE IMMUNOLOGY (2021)

Article Cell Biology

Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering

Jennifer R. Hamilton et al.

Summary: A new strategy has been developed in this study, which uses engineered lentiviral particles to introduce Cas9 RNPs and a CAR transgene into human T cells ex vivo, allowing targeting of specific cell types within a mixed population. This approach provides a method for genetic modification of immune cells without the need for electroporation.

CELL REPORTS (2021)

Article Oncology

NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity

Rebecca M. Richards et al.

Summary: CD93 CAR T cells show promising efficacy in eliminating AML while sparing HSPCs, but exhibit on-target, off-tumor toxicity to endothelial cells. Co-expression of other AML targets on endothelial cells is identified, and a novel NOT-gated strategy is introduced to mitigate endothelial toxicity, along with the use of high-dimensional transcriptomic profiling for rational design of combinatorial immunotherapies.

BLOOD CANCER DISCOVERY (2021)

Review Oncology

Tweak to Treat: Reprograming Bacteria for Cancer Treatment

Brendan Fu-Long Sieow et al.

Summary: Recent advances in cancer biology, microbiology, and bioengineering have led to the development of engineered live biotherapeutics for targeted cancer therapy. Engineered bacteria, including tumor-targeting and probiotics, can deliver anticancer agents to the tumor microenvironment. Combination therapies involving engineered bacteria and traditional anticancer treatments show promise in addressing intratumor heterogeneity. Exciting prospects lie ahead for the clinical translation of engineered bacteria in cancer prevention and treatment.

TRENDS IN CANCER (2021)

Article Biotechnology & Applied Microbiology

Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency

David N. Nguyen et al.

NATURE BIOTECHNOLOGY (2020)

Article Medicine, General & Internal

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

Enli Liu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors

Katharina Reinhard et al.

SCIENCE (2020)

Review Biochemistry & Molecular Biology

The Emerging Landscape of Immune Cell Therapies

Evan W. Weber et al.

Review Biochemistry & Molecular Biology

Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development

Jeong-Ryul Hwang et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Article Medicine, Research & Experimental

Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability

Sonia Guedan et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Oncology

Tuning the Antigen Density Requirement for CAR T-cell Activity

Robbie G. Majzner et al.

CANCER DISCOVERY (2020)

Article Biotechnology & Applied Microbiology

Human chimeric antigen receptor macrophages for cancer immunotherapy

Michael Klichinsky et al.

NATURE BIOTECHNOLOGY (2020)

Review Multidisciplinary Sciences

Network Approaches for Dissecting the Immune System

Hao Shi et al.

ISCIENCE (2020)

Article Multidisciplinary Sciences

cDC1 prime and are licensed by CD4+T cells to induce anti-tumour immunity

Stephen T. Ferris et al.

NATURE (2020)

Article Immunology

A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy

Shannon K. Oda et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Editorial Material Multidisciplinary Sciences

IMMUNOTHERAPY Engineering cytokines and cytokine circuits

Aileen W. Li et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Precise T cell recognition programs designed by transcriptionally linking multiple receptors

Jasper Z. Williams et al.

SCIENCE (2020)

Review Immunology

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Alex D. Waldman et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Medicine, Research & Experimental

T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy

Tori N. Yamamoto et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Multidisciplinary Sciences

CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

Mohamad Hamieh et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

Cascaded amplifying circuits enable ultrasensitive cellular sensors for toxic metals

Xinyi Wan et al.

NATURE CHEMICAL BIOLOGY (2019)

Review Medicine, Research & Experimental

Engineering and Design of Chimeric Antigen Receptors

Sonia Guedan et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)

Review Oncology

Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer

Shabnum Patel et al.

FRONTIERS IN ONCOLOGY (2019)

Article Biochemistry & Molecular Biology

Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity

Laurent Gauthier et al.

Review Biochemistry & Molecular Biology

Engineering cell-cell communication networks: programming multicellular behaviors

Satoshi Toda et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2019)

Article Multidisciplinary Sciences

Engineering dendritic cell vaccines to improve cancer immunotherapy

Caleb R. Perez et al.

NATURE COMMUNICATIONS (2019)

Review Biochemistry & Molecular Biology

Bacteria-cancer interactions: bacteria-based cancer therapy

Mai Thi-Quynh Duong et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency

Judith Feucht et al.

NATURE MEDICINE (2019)

Article Multidisciplinary Sciences

c-Jun overexpression in CAR T cells induces exhaustion resistance

Rachel C. Lynn et al.

NATURE (2019)

Article Medicine, General & Internal

NK cells specifically TCR-dressed to kill cancer cells

Nadia Mensali et al.

EBIOMEDICINE (2019)

Article Biochemistry & Molecular Biology

Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses

Jang Hwan Cho et al.

Review Immunology

Transcriptional programming of tissue-resident memory CD8+ T cells

J. Justin Milner et al.

CURRENT OPINION IN IMMUNOLOGY (2018)

Review Medicine, General & Internal

Chimeric Antigen Receptor Therapy

Carl H. June et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Biology

Chimeric antigen receptors that trigger phagocytosis

Meghan A. Morrissey et al.

Review Oncology

Tumor Antigen Escape from CAR T-cell Therapy

Robbie G. Majzner et al.

CANCER DISCOVERY (2018)

Review Immunology

Cell Biology of T Cell Receptor Expression and Regulation

Andres Alcover et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)

Review Immunology

Regulatory mechanisms in T cell receptor signalling

Guillaume Gaud et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Review Biochemistry & Molecular Biology

The Principles of Engineering Immune Cells to Treat Cancer

Wendell A. Lim et al.

Article Biochemistry & Molecular Biology

Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits

Kole T. Roybal et al.

Article Biochemistry & Molecular Biology

Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors

Leonardo Morsut et al.

Article Medicine, Research & Experimental

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

Leonid Cherkassky et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Medicine, Research & Experimental

CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients

Cameron J. Turtle et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Multidisciplinary Sciences

Synchronized cycles of bacterial lysis for in vivo delivery

M. Omar Din et al.

NATURE (2016)

Review Immunology

The multifaceted role of CD4+ T cells in CD8+ T cell memory

Brian J. Laidlaw et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Review Immunology

Insights into Cytokine-Receptor Interactions from Cytokine Engineering

Jamie B. Spangler et al.

ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)

Review Biochemistry & Molecular Biology

Making Sense of Transcription Networks

Trevor R. Sorrells et al.

Article Multidisciplinary Sciences

Remote control of therapeutic T cells through a small molecule-gated chimeric receptor

Chia-Yung Wu et al.

SCIENCE (2015)

Article Multidisciplinary Sciences

Tissue-based map of the human proteome

Mathias Uhlen et al.

SCIENCE (2015)

Article Multidisciplinary Sciences

Functional heterogeneity of human memory CD4+ T cell clones primed by pathogens or vaccines

Simone Becattini et al.

SCIENCE (2015)

Article Medicine, Research & Experimental

Dendritic cell vaccines containing lymphocytes produce improved immunogenicity in patients with cancer

Mayu O. Frank et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2014)

Review Biochemistry & Molecular Biology

Ultrasensitivity part I: Michaelian responses and zero-order ultrasensitivity

James E. Ferrell et al.

TRENDS IN BIOCHEMICAL SCIENCES (2014)

Review Biochemistry & Molecular Biology

Ultrasensitivity part II: multisite phosphorylation, stoichiometric inhibitors, and positive feedback

James E. Ferrell et al.

TRENDS IN BIOCHEMICAL SCIENCES (2014)

Review Biochemistry & Molecular Biology

Ultrasensitivity part III: cascades, bistable switches, and oscillators

James E. Ferrell et al.

TRENDS IN BIOCHEMICAL SCIENCES (2014)

Review Biochemistry & Molecular Biology

The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered

Hui K. Gan et al.

FEBS JOURNAL (2013)

Article Biotechnology & Applied Microbiology

Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells

Christopher C. Kloss et al.

NATURE BIOTECHNOLOGY (2013)

Article Biochemistry & Molecular Biology

The SILVA ribosomal RNA gene database project: improved data processing and web-based tools

Christian Quast et al.

NUCLEIC ACIDS RESEARCH (2013)

Editorial Material Cell Biology

Calcium Signaling

Martin D. Bootman

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)

Article Cell Biology

A Theory of Germinal Center B Cell Selection, Division, and Exit

Michael Meyer-Hermann et al.

CELL REPORTS (2012)

Review Biochemistry & Molecular Biology

The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation

Alexander Plotnikov et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)

Article Biochemistry & Molecular Biology

Tunable Signal Processing in Synthetic MAP Kinase Cascades

Ellen C. O'Shaughnessy et al.

Article Biochemistry & Molecular Biology

Ultrasensitivity in the Regulation of Cdc25C by Cdk1

Nicole B. Trunnell et al.

MOLECULAR CELL (2011)

Review Multidisciplinary Sciences

Synthetic Biology: Integrated Gene Circuits

Nagarajan Nandagopal et al.

SCIENCE (2011)

Review Genetics & Heredity

Synthetic biology: applications come of age

Ahmad S. Khalil et al.

NATURE REVIEWS GENETICS (2010)

Article Multidisciplinary Sciences

A synthetic-natural hybrid oscillator in human cells

Jared E. Toettcher et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments

Dorothea Busse et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

A tunable synthetic mammalian oscillator

Marcel Tigges et al.

NATURE (2009)

Article Multidisciplinary Sciences

Robust, tunable biological oscillations from interlinked positive and negative feedback loops

Tony Yu-Chen Tsai et al.

SCIENCE (2008)

Review Genetics & Heredity

Network motifs: theory and experimental approaches

Uri Alon

NATURE REVIEWS GENETICS (2007)

Article Biochemistry & Molecular Biology

Regulatory dynamics of synthetic gene networks with positive feedback

Yusuke T. Maeda et al.

JOURNAL OF MOLECULAR BIOLOGY (2006)

Article Biochemistry & Molecular Biology

The incoherent feed-forward loop accelerates the response-time of the gal system of Escherichia coli

S Mangan et al.

JOURNAL OF MOLECULAR BIOLOGY (2006)

Article Multidisciplinary Sciences

Interlinked fast and slow positive feedback loops drive reliable cell decisions

O Brandman et al.

SCIENCE (2005)

Review Immunology

Helping the CD8+ T-cell response

MJ Bevan

NATURE REVIEWS IMMUNOLOGY (2004)

Article Biochemistry & Molecular Biology

The coherent feedforward loop serves as a sign-sensitive delay element in transcription networks

S Mangan et al.

JOURNAL OF MOLECULAR BIOLOGY (2003)

Article Multidisciplinary Sciences

Rewiring MAP kinase pathways using alternative scaffold assembly mechanisms

SH Park et al.

SCIENCE (2003)

Article Multidisciplinary Sciences

Network motifs: Simple building blocks of complex networks

R Milo et al.

SCIENCE (2002)

Article Genetics & Heredity

Network motifs in the transcriptional regulation network of Escherichia coli

SS Shen-Orr et al.

NATURE GENETICS (2002)

Article Multidisciplinary Sciences

A synthetic oscillatory network of transcriptional regulators

MB Elowitz et al.

NATURE (2000)

Article Multidisciplinary Sciences

Construction of a genetic toggle switch in Escherichia coli

TS Gardner et al.

NATURE (2000)